SCHEMBL27895117

SCHEMBL27895117

OCCOc1ccc(C2(c3ccccc3O)c3ccccc3-c3cc(CO)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 12/20 0.43
▸ ALDH1A1 P00352 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TTR P02766 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ ALOX5AP P20292 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ AKR1A1 P14550 1/20 0.33
▸ AKR1B1 P15121 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27895116 0.90 PDK2 (0.44) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL27895118 0.89 PDK2 (0.48) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL29351148 0.80 PDK2 (0.54) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL17050236 0.80 PDK2 (0.54) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL30211372 0.80 PDK2 (0.54) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL194556 0.80 PDK2 (0.54) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL27878248 0.78 CA12 (0.48) —
SCHEMBL27878251 0.78 PDK2 (0.49) PDK2ALDH1A1ESR1ESR2KDM4E
SCHEMBL21215204 0.78 PDK2 (0.49) PDK2ALDH1A1RECQLESR1ESR2
SCHEMBL20411195 0.77 ALDH1A1 (0.55) PDK2ALDH1A1RECQLESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102727470-A Application of fluorene-9-bisphenol and its derivative in preparation of medicine for preventing and treating cancer UNIV BEIJING 2012-10-17 — — CN disclosed
Send feedback